Tube-wrapped lamp makes malaria drug
20 January 2012
German researchers have developed an inexpensive three-step continuous flow synthesis of artemisinin, the key drug in the ongoing fight against malaria. François Lévesque and Peter Seeberger from the Max Planck Institute for Colloids and Interfaces in Potsdam say that their approach could supplement existing production, improving the drug's availability.
After only four and a half minutes in the flow reactor, artemisinic acid is converted into artemisinin
© Ulrich Kleiner
Artemisinin is the most effective therapy in the fight against the plasmodium parasites responsible for more than 200 million cases of malaria each year. Currently, the drug is extracted from sweet wormwood plants. This means that supplies of artemisinin are limited. And its fused ring structure with an endoperoxide group, which gives it its killing power, makes synthesising it from scratch impractical. Consequently, Seeberger and Lévesque instead began their synthesis from artemisinic acid, a by-product generated by current artemisinin production in quantities up to 10 times the mass of the drug. It can also be produced by genetically-engineered yeast.
Photochemically produced singlet oxygen aids the conversion of artemisinic acid to the drug artemisinin
© Angew. Chem., Int. Ed.
The two chemists began by reducing artemisinic acid to dihydroartemisinic acid, prior to the critical synthetic step of reacting it with singlet oxygen to form a hydroperoxide. The highly reactive singlet oxygen molecule must be produced by a photochemical reaction. This can trouble large-scale manufacturing, as light only penetrates a limited distance into batch reactors. However, by pumping reagents continuously through tubes wrapped around a lamp, Seeberger and Lévesque could illuminate the entire solution efficiently.
Martyn Poliakoff, at University of Nottingham, UK, who has also investigated singlet oxygen flow chemistry, calls the artemisinin synthesis 'an elegant piece of work'. 'I hope it will promote interest in continuous flow reactions and photochemistry,' he commented. 'I also hope it will lead to more widely available treatments for malaria.'
Seeberger shares a similar outlook, with a spin-out company based on the technology in the pipeline. 'I'm very excited about the prospect of being able to get this to the people who need it,' he says.
Interesting? Spread the word using the 'tools' menu on the left.
F Lévesque and P H Seeberger, Angew. Chem., Int. Ed., 2012, DOI: 10.1002/anie.201107446
Also of interest
Modernizing traditional Chinese medicine
There are 250 million cases of malaria each year, and effective medication is expensive and in short supply. Justine Davies explores possible solutions
Flow chemistry is poised to become an important tool for new drug development
19 December 2007
China's artemisinin producers face market collapse
Comment on this story at the Chemistry World blog
Read other posts and join in the discussion
External links will open in a new browser window